We also wanted to verify whether activation of CC (C3a, C5a and C5b-9/MAC) may be associated with increased numbers of circulating BMSCs, that are observed in patients with pancreatic cancer. This evidence concerns the gene CXCR1 and familial pancreatic carcinoma.